Clinical Trial Update: Microglial Activation Role In ALS (MARIA) [EARLY_Phase 1]

View source ↗

Summary

The MARIA trial, an early phase 1 study examining microglial activation in amyotrophic lateral sclerosis, has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Snippet

Sponsor: University Hospital, Tours | Conditions: Amyotrophic Lateral Sclerosis | EARLY_Phase 1 | Status: WITHDRAWN